"Glucometrics"--assessing the quality of inpatient glucose management.

"Glucometrics"--assessing the quality of inpatient glucose management. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

"Glucometrics"--assessing the quality of inpatient glucose management. Abstract Text:

Philip A Goldberg,Janis E Bozzo,Prem G Thomas,Melinda M Mesmer,Olga V Sakharova,Martha J Radford,Silvio E Inzucchi,

BACKGROUND: For patients with diabetes, the quality of outpatient glycemic control is readily assessed by hemoglobin A1c. In contrast, standardized measures for assessing the quality of blood glucose (BG) management in hospitalized patients are lacking. Because of recent studies demonstrating the benefits of strict glycemic control in critically ill patients, hospitals nationwide are dedicating resources to address this important issue. To facilitate advances in this nascent field, standardized metrics for inpatient glycemic control should be developed and validated. METHODS: We used 1 month of fingerstick BG levels from a general hospital ward to develop and test three analytic models, based on three units of inpatient BG analysis: population (i.e., ward), patient-day, and patient. To assess the effect of the source of blood samples, we repeated these analyses after adding venous plasma glucose levels. Finally, we employed an idealized intensive care unit data set to establish "gold standard" metrics for inpatient glycemic control. RESULTS: Mean and median BG levels and the proportion of BG levels within an "optimal" range (80-139 mg/dL) were similar among the three models, whereas hypoglycemic and hyperglycemic event rates varied considerably. Inclusion of venous glucose levels did not substantially affect the results. Of the three models tested, the patient-day model appears to most faithfully reflect the quality of inpatient glycemic control. Achieving 85% of BG levels within optimal range may be considered gold standard. CONCLUSIONS: If validated elsewhere, these "glucometrics" would permit objective comparisons of inpatient glycemic control among hospitals and patient care units, and would allow institutions to gauge the success of their quality improvement initiatives.

"Glucometrics"--assessing the quality of inpatient glucose management. Publishing Authors By Initials

PA Goldberg,JE Bozzo,PG Thomas,MM Mesmer,OV Sakharova,MJ Radford,SE Inzucchi,

For similar natural sciences: weights and measures: reference standards research abstracts see: natural sciences: weights and measures: reference standards research

PUBMED ID PMID:

MEDLINE DATE:

"Glucometrics"--assessing the quality of inpatient glucose management. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Diabetes technology & therapeutics

VOLUME: 8

Page Numbers: 560-9

Journal Abbreviation: Diabetes Technol. Ther.

ISSN: 1520-9156

DAY: 3

MONTH: Oct

YEAR: 2006

"Glucometrics"--assessing the quality of inpatient glucose management. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100889084

"Glucometrics"--assessing the quality of inpatient glucose management. Keywords Mesh Terms:

KEYWORDS: Reference Standards

MESH TERMS: standards

Chemical & Substance for Abstract: "Glucometrics"--assessing the quality of inpatient glucose management. Information

Substance Name: Blood Glucose

Registry Number: 0

Grant and Affiliation Information for "Glucometrics"--assessing the quality of inpatient glucose management.

AFFILIATION: Section of Endocrinology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

Country: United States

AGENCY: United States NLM

GRANT: T15 LM07065

ACRONYM: LM

MEDLINETA: Diabetes Technol Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

"Glucometrics"--assessing the quality of inpatient glucose management Related Publications

• "Glucometrics"--assessing the quality of inpatient glucose management.
• "Waste not, want not": determining the optimal priming volume for intravenous insulin infusions.
• A patient with type B insulin resistance syndrome, responsive to immune therapy.
• Computing performance measures for inpatient glucose management.
• Diabetes mellitus, insulin resistance, hyperglycemia, and stroke.
• Endocrine assessments during critical illness.
• Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
• New drugs for the treatment of diabetes mellitus: part I: thiazolidinediones and their evolving cardiovascular implications.
• Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study.